Lipidor Ab (Sweden) Insiders
| LIPI Stock | SEK 0.19 0.00 0.00% |
Lipidor Ab employs about 6 people. The company is managed by 15 executives with a total tenure of roughly 60 years, averaging almost 4.0 years of service per executive, having 0.4 employees per reported executive. Breaking down Lipidor Ab's management performance can provide insight into the firm performance.
| Ola Holmlund CEO Chief Executive Officer |
Lipidor |
Lipidor Ab Management Team Effectiveness
The company has return on total asset (ROA) of (0.6425) % which means that it has lost $0.6425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3463) %, meaning that it generated substantial loss on money invested by shareholders. Lipidor Ab's management efficiency ratios could be used to measure how well Lipidor Ab manages its routine affairs as well as how well it operates its assets and liabilities.Lipidor Ab Workforce Comparison
Lipidor Ab is currently regarded as number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is now estimated at about 423,097. Lipidor Ab adds roughly 6.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
Lipidor Ab Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Lipidor Ab Price Series Summation is a cross summation of Lipidor Ab price series and its benchmark/peer.
Lipidor Ab Notable Stakeholders
A Lipidor Ab stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lipidor Ab often face trade-offs trying to please all of them. Lipidor Ab's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lipidor Ab's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ola Holmlund | Chief Executive Officer | Profile | |
| Michael Owens | Chief Financial Officer | Profile | |
| Charlotta Ekman | Chief Officer | Profile | |
| Olle Holmertz | Founder Controller | Profile | |
| Ola Flink | Independent Chairman of the Board | Profile | |
| Gunilla Lundmark | Independent Director | Profile | |
| Per Nilsson | Director | Profile | |
| Fredrik Sjovall | Independent Director | Profile | |
| Jan Holmback | Research Director | Profile | |
| Anders Hagman | Chief Officer | Profile | |
| Anders Carlsson | Sr CoFounder | Profile | |
| Bengt Herslf | Cofounder Advisor | Profile | |
| Jan Holmbck | CoFounder Officer | Profile | |
| Gerhard Miksche | CoFounder | Profile | |
| Gabriel Haering | Director | Profile |
About Lipidor Ab Management Performance
The success or failure of an entity such as Lipidor Ab often depends on how effective the management is. Lipidor Ab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lipidor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lipidor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Lipidor AB , a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. Lipidor AB was founded in 2009 and is based in Stockholm, Sweden. Lipidor AB is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Lipidor Ab's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lipidor Ab. Check Lipidor Ab's Beneish M Score to see the likelihood of Lipidor Ab's management manipulating its earnings.
Lipidor Ab Workforce Analysis
Traditionally, organizations such as Lipidor Ab use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lipidor Ab within its industry.Lipidor Ab Manpower Efficiency
Return on Lipidor Ab Manpower
| Revenue Per Employee | 2.6M | |
| Revenue Per Executive | 1M | |
| Net Loss Per Employee | 3.5M | |
| Net Loss Per Executive | 1.4M |
Additional Tools for Lipidor Stock Analysis
When running Lipidor Ab's price analysis, check to measure Lipidor Ab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipidor Ab is operating at the current time. Most of Lipidor Ab's value examination focuses on studying past and present price action to predict the probability of Lipidor Ab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipidor Ab's price. Additionally, you may evaluate how the addition of Lipidor Ab to your portfolios can decrease your overall portfolio volatility.